Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

被引:88
|
作者
Banerjee, Suvankar [1 ]
Adhikari, Nilanjan [1 ,2 ]
Amin, Sk Abdul [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Nat Sci Lab, Div Med & Pharmaceut Chem, POB 17020, Kolkata 700032, W Bengal, India
[2] ADAMAS Univ, Sch Pharmaceut Technol, Barasat Barrackpore Rd,PO Jagannathpur, Kolkata 700126, W Bengal, India
关键词
Histone deacetylase; HDAC8; Cancer; inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR); DE-LANGE-SYNDROME; SUBEROYLANILIDE HYDROXAMIC ACID; ZINC-BINDING GROUP; BIOLOGICAL EVALUATION; PHASE-I; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; ACTIVITY ASSAY; UP-REGULATION; DESIGN;
D O I
10.1016/j.ejmech.2018.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:214 / 240
页数:27
相关论文
共 50 条
  • [31] Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
    Tang, Guozhi
    Wong, Jason C.
    Zhang, Weixing
    Wang, Zhanguo
    Zhang, Nan
    Peng, Zhenghong
    Zhang, Zhenshan
    Rong, Yiping
    Li, Shijie
    Zhang, Meifang
    Yu, Lingjie
    Feng, Teng
    Zhang, Xiongwen
    Wu, Xihan
    Wu, Jim Z.
    Chen, Li
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) : 8026 - 8034
  • [32] On the inhibition of histone deacetylase 8
    Estiu, Guillermina
    West, Nathan
    Mazitschek, Ralph
    Greenberg, Edward
    Bradner, James E.
    Wiest, Olaf
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (11) : 4103 - 4110
  • [33] Restoring Histone Deacetylase Activity by Waste Product Release. A View from Molecular Mechanics Simulations with Mammalian HDAC8
    Pietra, Francesco
    CHEMISTRY & BIODIVERSITY, 2015, 12 (04) : 503 - 512
  • [34] Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery
    Thangapandian, Sundarapandian
    John, Shalini
    Lee, Yuno
    Kim, Songmi
    Lee, Keun Woo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (12) : 9440 - 9462
  • [35] Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors
    Zhao, Chunlong
    Zang, Jie
    Ding, Qin'ge
    Inks, Elizabeth S.
    Xu, Wenfang
    Chou, C. James
    Zhang, Yingjie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 282 - 291
  • [36] Inhibition and Mechanism of HDAC8 Revisited
    Chen, Kai
    Zhang, Xiaoxiao
    Wu, Yun-Dong
    Wiest, Olaf
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (33) : 11636 - 11643
  • [37] Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning
    Amin, Sk Abdul
    Adhikari, Nilanjan
    Jha, Tarun
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (01) : 1 - 8
  • [38] The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors
    Sodji, Quaovi
    Patil, Vishal
    Jain, Surendra
    Kornacki, James R.
    Mrksich, Milan
    Tekwani, Babu L.
    Oyelere, Adegboyega K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (20) : 4826 - 4830
  • [39] Selective and nonselective HDAC8 inhibitors: a therapeutic patent review
    Adhikari, Nilanjan
    Amin, Sk Abdul
    Jha, Tarun
    PHARMACEUTICAL PATENT ANALYST, 2018, 7 (06) : 259 - 276
  • [40] Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
    Traore, Mohamed D. M.
    Zwick, Vincent
    Simoes-Pires, Claudia A.
    Nurisso, Alessandra
    Issa, Mark
    Cuendet, Muriel
    Maynadier, Marjorie
    Wein, Sharon
    Vial, Henri
    Jamet, Helene
    Wong, Yung-Sing
    ACS OMEGA, 2017, 2 (04): : 1550 - 1562